- Datum15.01.2025
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Thomas May
Moderator
Roche Holding AG Aktie
Verkaufen
Kaufen
Roche Holding AG Chart
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
Roche Holding AG Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Baader | VK | |||||
| L&S weekend | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (L&S)
0,35 %
Intraday
1,50 %
1 Woche
-1,53 %
1 Monat
1,50 %
Seit Jahresbeginn
2,83 %
1 Jahr
-28,66 %
3 Jahre
0,28 %
5 Jahre
Wikifolio
Passender Service zu Roche Holding AG
Webinar zu Roche Holding AG
Kursinformationen (L&S)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)233,600-328,800
- Jahrestief / Hoch (€)233,600-328,800
- Schlusskurs (Vortag)
- Eröffnungskurs
Wichtigste Eigenschaften
Dividenden von Roche Holding AG
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2026 (e) | ||
| - | 2025 (e) | ||
| - | 2024 (e) | ||
| 14.03.2024 | 2023 | 9,60 Fr | 3,79 % |
| 16.03.2023 | 2022 | 9,50 Fr | 3,34 % |
| 17.03.2022 | 2021 | 9,30 Fr | 2,39 % |
| 18.03.2021 | 2020 | 9,10 Fr | 2,85 % |
| 19.03.2020 | 2019 | 9,00 Fr | 3,22 % |
| 07.03.2019 | 2018 | 8,70 Fr | 3,15 % |
| 15.03.2018 | 2017 | 8,30 Fr | 3,58 % |
| 16.03.2017 | 2016 | 8,20 Fr | 3,18 % |
| 03.03.2016 | 2015 | 8,10 Fr | 3,13 % |
| 05.03.2015 | 2014 | 8,00 Fr | - |
| 06.03.2014 | 2013 | 7,80 Fr | - |
| 07.03.2013 | 2012 | 7,35 Fr | - |
| 08.03.2012 | 2011 | 6,80 Fr | - |
| 03.03.2011 | 2010 | 6,60 Fr | - |
| 04.03.2010 | 2009 | 6,00 Fr | - |
| 16.03.2009 | 2008 | 5,00 Fr | - |
| 07.03.2008 | 2007 | 4,60 Fr | - |
| 08.03.2007 | 2006 | 3,40 Fr | - |
| 02.03.2006 | 2005 | 2,50 Fr | - |
| 03.03.2005 | 2004 | 2,00 Fr | - |
| 13.04.2004 | 2003 | 1,65 Fr | - |
| 04.04.2003 | 2002 | 1,45 Fr | - |
| 19.04.2002 | 2001 | 1,30 Fr | - |
| 06.04.2001 | 2000 | 115,00 Fr | - |
| 12.05.2000 | 1999 | 100,00 Fr | - |
| 23.04.1999 | 1998 | 87,00 Fr | - |
| 08.05.1998 | 1997 | 83,00 Fr | - |
| 09.05.1997 | 1996 | 75,00 Fr | - |
| 05.06.1996 | 1995 | 36,00 Fr | - |
| 05.06.1996 | 1995 | 64,00 Fr | - |
| 02.06.1995 | 1994 | 55,00 Fr | - |
| 03.06.1994 | 1993 | 48,00 Fr | - |
| 04.06.1993 | 1992 | 37,00 Fr | - |
| 01.06.1992 | 1991 | 28,00 Fr | - |
| 07.06.1991 | 1990 | 42,00 Fr | - |
| 23.05.1990 | 1989 | 38,00 Fr | - |
| 01.06.1989 | 1988 | 190,00 Fr | - |
| 01.06.1989 | 1988 | 800,00 Fr | - |
| 06.01.1989 | 1988 | 725,00 Fr | - |
| 09.06.1988 | 1987 | 660,00 Fr | - |
| 08.01.1988 | 1987 | 660,00 Fr | - |
| 05.06.1987 | 1986 | 625,00 Fr | - |
| 09.01.1987 | 1986 | 660,00 Fr | - |
| 06.06.1986 | 1985 | 625,00 Fr | - |
| 06.01.1986 | 1985 | 660,00 Fr | - |
| 07.06.1985 | 1985 | 600,00 Fr | - |
| 03.01.1985 | 1984 | 625,00 Fr | - |
| 07.06.1984 | 1983 | 575,00 Fr | - |
| 03.01.1984 | 1983 | 625,00 Fr | - |
| 06.06.1983 | 1982 | 550,00 Fr | - |
| 03.01.1983 | 1982 | 600,00 Fr | - |
| 07.06.1982 | 1981 | 550,00 Fr | - |
| 04.01.1982 | 1981 | 575,00 Fr | - |
| 04.06.1981 | 1980 | 550,00 Fr | - |
Termine von Roche Holding AG
Keine aktuellen Termine
Beschreibung
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.
